Buy Ketamine Injection 500mg/10ml Online

Ketamine Injection 500mg/10ml is a rapid-acting parenteral anesthetic solution widely utilized across human and veterinary medicine for surgical induction, short procedural anesthesia, and acute somatic pain management. As a dissociative anesthetic agent, it induces central nervous system detachment and profound analgesia while preserving essential autonomic respiratory and cardiovascular reflexes.

What Is Ketamine Injection 500mg/10ml?

Ketamine Injection 500mg/10ml is a sterile parenteral formulation containing Ketamine Hydrochloride equivalent to $50\text{ mg}$ of ketamine base per $\text{mL}$. Classified as an NMDA ($N$-methyl-$D$-aspartate) receptor antagonist, it produces a state of “dissociative anesthesia,” characterized by:

• Somatic Analgesia: Potent suppression of central and peripheral pain signaling pathways.

• Functional Brain Dissociation: Unconsciousness where the patient is electroencephalographically disconnected from their immediate environment.

• Preserved Reflexes: Maintenance of normal pharyngeal, laryngeal, corneal, and protective airway reflexes.

• Cardiovascular Support: Mild sympathomimetic action that helps maintain blood pressure and heart rate during induction.

Product Overview

Ketamine Injection 500mg/10ml provides a versatile, medium-concentration formulation ($50\text{ mg/mL}$) suitable for direct intravenous (IV) titration, intramuscular (IM) administration, or continuous rate infusion (CRI) preparation.

Key Features of Ketamine Injection 500mg/10ml

• Versatile $50\text{ mg/mL}$ Concentration: Allows precise volumetric titration for smaller patients or controlled infusions without excessive dilution.

• Rapid Onset of Action: Fast-acting induction within 30 to 60 seconds via IV, and 3 to 5 minutes via IM routes.

• Cardiovascular Safety Margin: Stimulates the sympathetic nervous system, maintaining cardiac output and mean arterial blood pressure.

• Preserved Airway Reflexes: Maintains pharyngeal tone and spontaneous breathing, providing an added layer of safety during brief interventions.

• Synergistic Protocol Flexibility: Blends into balanced anesthetic and analgesic multi-drug protocols alongside sedatives, opioids, and muscle relaxants.

Product Specifications and Presentation

Ketamine Prices, 500mg/10ml is manufactured under strict pharmaceutical standards to ensure sterility, pyrogen-free quality, and exact concentration:

• Total Content: $500\text{ mg}$ Ketamine base in a $10\text{ mL}$ multi-dose or single-dose glass vial.

• Concentration: $50\text{ mg/mL}$.

• Excipients: Benzethonium chloride or chlorobutanol as a preservative (in multi-dose formats), sodium chloride for isotonicity, and water for injection (pH adjusted to $3.5\text{–}5.5$).

• Appearance: Clear, colorless sterile aqueous liquid.

Mechanism of Action

Ketamine operates primarily through non-competitive antagonism of central $N$-methyl-$D$-aspartate (NMDA) receptors:

                      [ Ketamine Injection 500mg/10ml (50mg/mL) ]
                                          │
            ┌─────────────────────────────┴─────────────────────────────┐
            ▼                                                           ▼
 [ Non-Competitive NMDA Antagonism ]                         [ Inhibition of Glutamate Pathways ]
            │                                                           │
            ▼                                                           ▼
 [ Thalamocortical & Limbic Dissociation ]                   [ Blockade of Central "Wind-Up" Pain ]
            │                                                           │
            ▼                                                           ▼
 [ Somatic Analgesia & Sedative State ]                      [ Prevention of Hyperalgesia ]
            │                                                           │
            └─────────────────────────────┬─────────────────────────────┘
                                          │
                                          ▼
                      [ Anesthesia & Perioperative Analgesia ]

1. Thalamocortical Dissociation: Electrically decouples the limbic system from the neocortex, blocking conscious pain perception while preserving lower brainstem function.

2. NMDA Antagonism & Wind-Up Suppression: Blocks glutamate binding at NMDA receptors, preventing central nervous system sensitization (“wind-up” pain) and hyperalgesia.

3. Sympathomimetic Action: Inhibits neuronal catecholamine reuptake, providing central sympathetic stimulation that maintains hemodynamic stability.

Clinical Uses and Applications

1. Surgical Induction & Anesthesia

Used for rapid anesthetic induction prior to inhalation agent maintenance or as a sole agent for short diagnostic and minor surgical procedures.

2. Procedural Sedation & Analgesia

Ideal for brief, painful interventions such as wound debridement, fracture reduction, and dressing changes where maintaining spontaneous respiration is beneficial.

3. Sub-Anesthetic Pain Management

Administered at micro-doses via Continuous Rate Infusion (CRI) as an adjunctive analgesic to reduce opioid requirements and prevent central sensitization.

Safety Considerations and Monitoring

+-----------------------------------------------------------------------------------+
|                                 SAFETY WARNING                                    |
|  1. REQUIREMENT FOR SEDATIVE CO-ADMINISTRATION: Ketamine used alone may cause    |
|     hypertonia, muscle rigidity, or emergence reactions.                         |
|  2. CONTROLLED SUBSTANCE: Store, log, and handle in compliance with legal laws.   |
|  3. MONITORING: Continuously track blood pressure, heart rate, oxygenation, and   |
|     respiratory function during administration.                                   |
+-----------------------------------------------------------------------------------+

• Muscle Hypertonia: Ketamine can cause elevated muscle tone when administered without co-agents. It is standard practice to combine it with a benzodiazepine or $\alpha_2$-agonist to ensure smooth relaxation.

• Emergence Reactions: Emergence delirium, vivid dreams, or transient agitation can occur as the medication wears off, which can be mitigated by co-administering sedatives.

Benefits and Important Considerations

Benefits

• Hemodynamic Stability: Supports blood pressure in hypotensive or high-risk cases compared to depressant anesthetics.

• Bronchodilatory Effects: Relaxes bronchial smooth muscle, making it useful in patients with reactive airway disease.

• Analgesic Sparing: Decreases overall post-operative opioid consumption through NMDA blockade.

Considerations

• Increased Secretions: May increase salivation and tracheobronchial secretions; anticholinergic premedication may be considered.

• Intraocular & Intracranial Pressure: Can cause transient increases in intraocular and intracranial pressure.

Administration and Dosage Guidelines

Note: Dosing must be determined by a qualified healthcare or veterinary professional based on patient weight, health status, and clinical objective.

General Dosing Reference

• Intravenous (IV) Induction: Typically ranges from $1.0\text{ mg/kg}$ to $2.0\text{ mg/kg}$ given slowly over 60 seconds.

• Intramuscular (IM) Induction: Typically ranges from $5.0\text{ mg/kg}$ to $10.0\text{ mg/kg}$ when IV access is limited.

• Sub-Anesthetic Infusion (CRI): Administered at low doses (e.g., $0.1\text{–}0.5\text{ mg/kg/hr}$) for adjunctive pain management.

Important Safety Information and Contraindications

1. Contraindications: Contraindicated in individuals with severe hypertension, uncompensated heart failure, elevated intracranial pressure, or known hypersensitivity to ketamine.

2. Airway Management: Although protective reflexes are maintained, respiratory depression can occur with rapid IV bolus administration.

3. Hepatic/Renal Impairment: Use with caution, as ketamine is metabolized by the liver and excreted by the kidneys.

Storage and Handling Guidelines

• Temperature: Store between 15°C and 25°C (59°F to 77°F). Do not freeze.

• Light Protection: Keep vial in its original carton to protect from light exposure.

• Controlled Access: Secure in a locked storage cabinet or safe according to national regulatory requirements for controlled substances.

Purchasing Considerations for Controlled Anesthetics

When procuring Ketamine Injection 500mg/10ml online:

• Licensing & Authorization: Requires valid professional medical or veterinary credentials and regulatory compliance.

• Concentration Verification: Confirm the formulation is $50\text{ mg/mL}$ ($500\text{ mg/10 mL}$) to ensure accurate dosing calculations.

• Authenticity & Integrity: Source exclusively through authorized, certified medical and veterinary supply platforms featuring intact tamper-evident seals and complete batch traceability.

Where To Buy Ketamine Injection Online

Acquiring certified clinical supplies and anesthetics is essential for patient care and surgical safety. World Equine Vet provides access to high-grade pharmaceuticals, anesthesia supplies, and healthcare products for licensed practitioners, clinical facilities, and veterinary operations globally.

At World Equine Vet, we prioritize supply authenticity, regulatory compliance, and reliable international fulfillment.

• Browse certified pharmaceutical offerings on the World Equine Vet platform.

• Access technical documentation and concentration data.

• Benefit from secure ordering and specialized global shipping.

Visit World Equine Vet today to explore our catalog.

Frequently Asked Questions (FAQs)

1. What does 500mg/10ml mean for Ketamine Injection?

It indicates a concentration of $50\text{ mg}$ of ketamine per $\text{mL}$, with a total volume of $10\text{ mL}$ providing $500\text{ mg}$ of active ingredient per vial.

2. How does Ketamine 500mg/10ml ($50\text{ mg/mL}$) differ from $100\text{ mg/mL}$ formulations?

The $50\text{ mg/mL}$ formulation is half the concentration of $100\text{ mg/mL}$ solutions. It allows for finer volume adjustments when titrating lower doses or preparing continuous infusions.

3. Can Ketamine Injection be given IM and IV?

Yes. Ketamine Injection 500mg/10ml is formulated for both Intravenous (IV) and Intramuscular (IM) administration.

4. Is Ketamine Injection a controlled substance?

Yes. Ketamine is a regulated controlled substance globally due to its potential for misuse and requires proper professional licensing to purchase and dispense.

5. How should open multi-dose vials be stored?

Store in a locked controlled-substance cabinet at controlled room temperature (15°C–25°C), protected from light, and use strict aseptic technique for every withdrawal.

Where To Buy ketamin Injection Online In USA

World Equine Vet Sells High Purity Ketamine Injection Only in USA. Ketamine Injection 500mg/10ml is a core parenteral anesthetic and analgesic agent offering rapid dissociative action, strong somatic analgesia, and hemodynamic stability. Its medium concentration provides maximum versatility for surgical induction, procedural sedation, and pain management protocols. Safe utilization requires strict professional oversight, appropriate co-administration of sedatives, and compliance with controlled substance regulations.

For verified medical and veterinary pharmaceuticals, visit World Equine Vet.

For the induction of anaesthesia prior to the administration of other general anaesthetic agents. To supplement other anaesthetic agents.

Specific areas of application or types of procedures :ketamin injection

When the intramuscular route of administration is preferred.

Debridement, painful dressings, and skin grafting in burned patients, as well as other superficial surgical procedures.

Neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms, and lumbar punctures.

Diagnostic and operative procedures of the eye, ear, nose, and mouth, including dental extractions.

Note: Eye movements may persist during ophthalmological procedures.ketamin injection

Anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided, if at all possible.

Orthopaedic procedures such as closed reductions, manipulations, femoral pinning, amputations, and biopsies.

Sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus.

Cardiac catheterization procedures.

Caesarean section; as an induction agent in the absence of elevated blood pressure.

Anaesthesia in the asthmatic patient, either to minimise the risks of an attack of bronchospasm developing, or in the presence of bronchospasm where anaesthesia cannot be delayed.

For intravenous infusion, intravenous injection or intramuscular injection.

NOTE: All doses are given in terms of ketamine base

Adults, elderly (over 65 years) and children:

For surgery in elderly patients ketamine has been shown to be suitable either alone or supplemented with other anaesthetic agents.

Preoperative preparations

Ketamine has been safely used alone when the stomach was not empty. However, since the need for supplemental agents and muscle relaxants cannot be predicted, when preparing for elective surgery it is advisable that nothing be given by mouth for at least six hours prior to anaesthesia.

Premedication with an anticholinergic agent (e.g. atropine, hyoscine or glycopyrolate) or another drying agent should be given at an appropriate interval prior to induction to reduce ketamine- induced hypersalivation.

Midazolam, diazepam, lorazepam, or flunitrazepam used as a premedicant or as an adjunct to ketamine, have been effective in reducing the incidence of emergence reactions.

Onset and duration

As with other general anaesthetic agents, the individual response to Ketamine is somewhat varied depending on the dose, route of administration, age of patient, and concomitant use of other agents, so that dosage recommendation cannot be absolutely fixed. The dose should be titrated against the patient’s requirements.

Because of rapid induction following intravenous injection, the patient should be in a supported position during administration. An intravenous dose of 2 mg/kg of bodyweight usually produces surgical anaesthesia within 30 seconds after injection and the anaesthetic effect usually lasts 5 to10 minutes. An intramuscular dose of 10 mg/kg of bodyweight usually produces surgical anaesthesia within 3 to 4 minutes following injection and the anaesthetic effect usually lasts 12 to 25 minutes. Return to consciousness is gradual.

A. Ketamine as the sole anaesthetic agent

Intravenous Infusion

The use of Ketamine by continuous infusion enables the dose to be titrated more closely, thereby reducing the amount of drug administered compared with intermittent administration. This results in a shorter recovery time and better stability of vital signs.

A solution containing 1 mg/ml of ketamine in dextrose 5% or sodium chloride 0.9% is suitable for administration by infusion.

General Anaesthesia Induction

An infusion corresponding to 0.5 – 2 mg/kg as total induction dose.

Maintenance of anaesthesia

Anaesthesia may be maintained using a microdrip infusion of 10 – 45 microgram/kg/min (approximately 1 – 3 mg/min).

The rate of infusion will depend on the patient’s reaction and response to anaesthesia. The dosage required may be reduced when a long acting neuromuscular blocking agent is used.

Intermittent Injection

Induction

Intravenous Route

The initial dose of Ketamine administered intravenously may range from 1 mg/kg to 4.5 mg/kg (in terms of ketamine base). The average amount required to produce 5 to 10 minutes of surgical anaesthesia has been 2.0 mg/kg. It is recommended that intravenous administration be accomplished slowly (over a period of 60 seconds). More rapid administration may result in respiratory depression and enhanced pressor response.

Dosage in Obstetrics

In obstetrics, for vaginal delivery or in caesarean section, intravenous doses ranging from 0.2 to 1.0 mg/kg are recommended (see section 4.6 Fertility, pregnancy and lactation).

Intramuscular Route

The initial dose of Ketamine administered intramuscularly may range from 6.5 mg/kg to 13 mg/kg (in terms of ketamine base). A low initial intramuscular dose of 4 mg/kg has been used in diagnostic manoeuvres and procedures not involving intensely painful stimuli. A dose of 10 mg/kg will usually produce 12 to 25 minutes of surgical anaesthesia.

Dosage in Hepatic Insufficiency

Dose reductions should be considered in patients with cirrhosis or other types of liver impairment. (see section 4.4 Special Warnings and Special Precautions for Use)

Dosage in Obstetrics

Data are lacking for intramuscular injection and maintenance infusion of ketamine in the parturient population, and recommendations cannot be made. Available data are presented in Section 5.2.

Maintenance of general anaesthesia

Lightening of anaesthesia may be indicated by nystagmus, movements in response to stimulation, and vocalization. Anaesthesia is maintained by the administration of additional doses of Ketamine by either the intravenous or intramuscular route.

Each additional dose is from ½ to the full induction dose recommended above for the route selected for maintenance, regardless of the route used for induction.

The larger the total amount of Ketamine administered, the longer will be the time to complete recovery.

Purposeless and tonic-clonic movements of extremities may occur during the course of anaesthesia. These movements do not imply a light plane and are not indicative of the need for additional doses of the anaesthetic.

B. Ketamine as induction agent prior to the use of other general anaesthetics

Induction is accomplished by a full intravenous or intramuscular dose of Ketamine as defined above. If Ketamine has been administered intravenously and the principal anaesthetic is slow- acting, a second dose of Ketamine may be required 5 to 8 minutes following the initial dose. If Ketamine has been administered intramuscularly and the principal anaesthetic is rapid-acting, administration of the principal anaesthetic may be delayed up to 15 minutes following the injection of Ketamine.